Does a positive tuberculin skin test (PPD) indicate latent tuberculosis infection?

Does a Positive PPD Mean You Have Latent TB?

A positive tuberculin skin test (PPD/TST) indicates an immune response to mycobacterial antigens but does not definitively confirm latent tuberculosis infection—it requires both a positive test AND exclusion of active disease, while recognizing that false positives occur from BCG vaccination and non-tuberculous mycobacteria. 1, 2

Understanding What the TST Actually Measures

The tuberculin skin test measures a delayed-type hypersensitivity (DTH) response that becomes detectable 2–12 weeks after primary M. tuberculosis infection 3. However, this test has critical limitations:

• The TST uses purified protein derivative (PPD), which is a crude mixture of antigens shared by M. tuberculosis, M. bovis BCG vaccine, and environmental mycobacteria 1
• This cross-reactivity results in lower specificity in populations with high BCG vaccination rates and environmental mycobacterial exposure 1
• None of the available tests can reliably distinguish latent TB infection from active tuberculosis or past tuberculosis 1

The Two-Step Requirement for LTBI Diagnosis

Latent TB infection diagnosis requires BOTH:

1. A positive test for infection (TST or IGRA)
2. Negative evaluation for active disease 2

This is crucial—the positive test alone is insufficient for diagnosis.

Common Causes of False-Positive Results

BCG Vaccination

• BCG vaccination causes positive TST reactions, though interferon-gamma release assays (IGRAs) are preferred in BCG-vaccinated populations 2
• The TST has lower specificity in these populations 1

Non-Tuberculous Mycobacteria (NTM)

• In one population-based study, 16% of positive PPD tests were actually attributable to NTM sensitization rather than true LTBI 4
• PPD reactions of 5-14 mm were more likely to be misclassified than those ≥15 mm (OR = 5.0,95% CI 1.9-13.2) 4
• 53% of contacts with positive TST were negative on more specific ELISPOT testing, with 76% responding to BCG antigens, suggesting BCG vaccination or NTM infection 5

Clinical Interpretation Algorithm

When interpreting a positive TST:

1. Measure the induration size: Reactions ≥15 mm are more likely to represent true M. tuberculosis infection than smaller reactions (5-14 mm), which have higher false-positive rates 4

2. Assess BCG vaccination history: If BCG-vaccinated, consider IGRA testing instead, as IGRAs have higher specificity 2, 5

3. Evaluate for active TB: Perform clinical assessment, chest radiography, and symptom screening—routine tuberculin testing is not a prerequisite for MMR vaccination in individuals without active tuberculosis 3

4. Consider NTM exposure risk: In areas with high environmental mycobacterial exposure, dual skin testing or IGRA confirmation may reduce misdiagnosis 4

Key Clinical Pitfalls

• Do not assume a positive TST equals LTBI without excluding active disease 2
• Both TST and IGRAs have low positive predictive values—the test indicates immune response, not necessarily viable dormant bacilli 2
• The TST cannot distinguish between latent infection, active disease, or past resolved infection 1
• Transient anergy during measles infection does not reflect true absence of latent infection, so timing relative to viral illnesses matters 3

When to Use Alternative Testing

Consider IGRA testing (QuantiFERON, T-SPOT.TB) when:

• Patient has received BCG vaccination 2
• Higher specificity is needed to avoid unnecessary treatment 5
• Cost and logistics permit (TST remains appropriate when these advantages exist) 2